Structures of human folate receptors reveal biological trafficking states and diversity in folate and antifolate recognition

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 38, 2013, Pages 15180-15188

  Wibowo, Ardian S ^a   Singh, Mirage ^a   Reeder, Kristen M ^a   Carter, Joshua J ^a   Kovach, Alexander R ^a   Meng, Wuyi ^a   Ratnam, Manohar ^b   Zhang, Faming ^a   Dann III, Charles E ^a  

^a INDIANA UNIVERSITY   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPTERIN; FOLATE RECEPTOR; FOLIC ACID; FOLIC ACID ANTAGONIST; METHOTREXATE; PEMETREXED;

ARTICLE; CONFORMATIONAL TRANSITION; DRUG PROTEIN BINDING; DRUG STRUCTURE; PH; PRIORITY JOURNAL; PROTEIN CONFORMATION;

ISOTHERMAL TITRATION CALORIMETRY; TARGETED DRUG DELIVERY;

ANIMALS; CHO CELLS; CHROMATOGRAPHY, AFFINITY; CRICETINAE; CRICETULUS; CRYSTALLIZATION; FOLATE RECEPTORS, GPI-ANCHORED; FOLIC ACID; FOLIC ACID ANTAGONISTS; HUMANS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; POLYMERASE CHAIN REACTION; PROTEIN CONFORMATION; PROTEIN TRANSPORT;

EID: 84884320882     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1308827110     Document Type: Article

References (78)

1. Hoffbrand AV, Weir DG (2001) The history of folic acid. Br J Haematol 113(3):579-589.
2. Kamen BA, Smith AK (2004) A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro. Adv Drug Deliv Rev 56(8):1085-1097.
3. Kamen BA, Wang MT, Streckfuss AJ, Peryea X, Anderson RG (1988) Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles. J Biol Chem 263(27):13602-13609.
4. Matherly LH, Goldman DI (2003) Membrane transport of folates. Vitam Horm 66: 403-456.
5. Zhao R, Matherly LH, Goldman ID (2009) Membrane transporters and folate homeostasis: Intestinal absorption and transport into systemic compartments and tissues. Expert Rev Mol Med 11:e4.
6. Goldman ID, Chattopadhyay S, Zhao R, Moran R (2010) The antifolates: Evolution, new agents in the clinic, and how targeting delivery via specific membrane transporters is driving the development of a next generation of folate analogs. Curr Opin Investig Drugs 11(12):1409-1423.
7. Matherly LH, Hou Z (2008) Structure and function of the reduced folate carrier a paradigm of a major facilitator superfamily mammalian nutrient transporter. Vitam Horm 79:145-184.
8. Farber S, Diamond LK (1948) Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. N Engl J Med 238(23):787-793.
9. Burchenal JH, et al. (1951) The effects of the folic acid antagonists and 2,6-diaminopurine on neoplastic disease, with special reference to acute leukemia. Cancer 4(3):549-569.
10. Huennekens FM (1994) The methotrexate story: A paradigm for development of cancer chemotherapeutic agents. Adv Enzyme Regul 34:397-419.
11. Visentin M, Zhao R, Goldman ID (2012) The antifolates. Hematol Oncol Clin North Am 26(3):629-648, ix.
12. Jackman AL, Theti DS, Gibbs DD (2004) Antifolates targeted specifically to the folate receptor. Adv Drug Deliv Rev 56(8):1111-1125.
13. Gibbs DD, et al. (2005) BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors. Cancer Res 65(24): 11721-11728.
14. Cronstein BN (2005) Low-dose methotrexate: A mainstay in the treatment of rheumatoid arthritis. Pharmacol Rev 57(2):163-172.
15. Qiu A, et al. (2006) Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 127(5):917-928.
16. Liu M, et al. (2005) Structure and regulation of the murine reduced folate carrier gene: Identification of four noncoding exons and promoters and regulation by dietary folates. J Biol Chem 280(7):5588-5597.
17. Qiu A, et al. (2007) Rodent intestinal folate transporters (SLC46A1): Secondary structure, functional properties, and response to dietary folate restriction. Am J Physiol Cell Physiol 293(5):C1669-C1678.
18. Sirotnak FM, Donsbach RC (1972) Comparative studies on the transport of aminopterin, methotrexate, and methasquin by the L1210 leukemia cell. Cancer Res 32(10): 2120-2126.
19. Min SH, et al. (2008) The clinical course and genetic defect in the PCFT gene in a 27-year-old woman with hereditary folate malabsorption. J Pediatr 153(3):435-437.
20. Zhao R, Hanscom M, Chattopadhyay S, Goldman ID (2004) Selective preservation of pemetrexed pharmacological activity in HeLa cells lacking the reduced folate carrier: Association with the presence of a secondary transport pathway. Cancer Res 64(9): 3313-3319.
21. Chattopadhyay S, Moran RG, Goldman ID (2007) Pemetrexed: Biochemical and cellular pharmacology, mechanisms, and clinical applications. Mol Cancer Ther 6(2): 404-417.
22. Xia W, Low PS (2010) Folate-targeted therapies for cancer. J Med Chem 53(19): 6811-6824.
23. Leamon CP, Jackman AL (2008) Exploitation of the folate receptor in the management of cancer and inflammatory disease. Vitam Horm 79:203-233.
24. Elnakat H, Ratnam M (2004) Distribution, functionality and gene regulation of folate receptor isoforms: Implications in targeted therapy. Adv Drug Deliv Rev 56(8): 1067-1084.
25. Antony AC, Utley C, Van Horne KC, Kolhouse JF (1981) Isolation and characterization of a folate receptor from human placenta. J Biol Chem 256(18):9684-9692.
26. Ratnam M, Marquardt H, Duhring JL, Freisheim JH (1989) Homologous membrane folate binding proteins in human placenta: Cloning and sequence of a cDNA. Biochemistry 28(20):8249-8254.
27. Antony AC (2004) Folate receptors: Reflections on a personal odyssey and a perspective on unfolding truth. Adv Drug Deliv Rev 56(8):1059-1066.
28. Parker N, et al. (2005) Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem 338(2): 284-293.
29. Shen F, Ross JF, Wang X, Ratnam M (1994) Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity. Biochemistry 33(5):1209-1215.
30. Lacey SW, Sanders JM, Rothberg KG, Anderson RG, Kamen BA (1989) Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol. J Clin Invest 84(2):715-720.
31. Maziarz KM, Monaco HL, Shen F, Ratnam M (1999) Complete mapping of divergent amino acids responsible for differential ligand binding of folate receptors alpha and beta. J Biol Chem 274(16):11086-11091.
32. Wu M, Fan J, Gunning W, Ratnam M (1997) Clustering of GPI-anchored folate receptor independent of both cross-linking and association with caveolin. J Membr Biol 159(2):137-147.
33. Weitman SD, et al. (1992) Cellular localization of the folate receptor: Potential role in drug toxicity and folate homeostasis. Cancer Res 52(23):6708-6711.
34. Wu M, Gunning W, Ratnam M (1999) Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix. Cancer Epidemiol Biomarkers Prev 8(9):775-782.
35. Chancy CD, et al. (2000) Expression and differential polarization of the reduced-folate transporter-1 and the folate receptor alpha in mammalian retinal pigment epithelium. J Biol Chem 275(27):20676-20684.
36. Salazar MD, Ratnam M (2007) The folate receptor: What does it promise in tissuetargeted therapeutics? Cancer Metastasis Rev 26(1):141-152.
37. Puig-Kröger A, et al. (2009) Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages. Cancer Res 69(24):9395-9403.
38. Ross JF, Chaudhuri PK, Ratnam M (1994) Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 73(9):2432-2443.
39. Reddy JA, et al. (1999) Expression and functional characterization of the beta-isoform of the folate receptor on CD34(+) cells. Blood 93(11):3940-3948.
40. Shen F,Wu M, Ross JF, Miller D, RatnamM(1995) Folate receptor type gamma is primarily a secretory protein due to lack of an efficient signal for glycosylphosphatidylinositol modification: Protein characterization and cell type specificity. Biochemistry 34(16): 5660-5665.
41. Rijnboutt S, et al. (1996) Endocytosis of GPI-linked membrane folate receptor-alpha. J Cell Biol 132(1-2):35-47.
42. Sabharanjak S, Mayor S (2004) Folate receptor endocytosis and trafficking. Adv Drug Deliv Rev 56(8):1099-1109.
43. Ross JF, et al. (1999) Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia. Cancer 85(2):348-357.
44. Bueno R, Appasani K, Mercer H, Lester S, Sugarbaker D (2001) The alpha folate receptor is highly activated in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 121(2):225-233.
45. Adams PD, et al. (2002) PHENIX: Building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr 58(Pt 11): 1948-1954.
46. Nakashima-Matsushita N, et al. (1999) Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis. Arthritis Rheum 42(8):1609-1616.
47. Weinblatt ME, et al. (1992) Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update. Arthritis Rheum 35(2):129-137.
48. Zhao XB, Lee RJ (2004) Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptor. Adv Drug Deliv Rev 56(8): 1193-1204.
49. Kim SH, Jeong JH, Chun KW, Park TG (2005) Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate. Langmuir 21(19):8852-8857.
50. van Dam GM, et al. (2011) Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: First in-human results. Nat Med 17(10): 1315-1319.
51. Deng Y, et al. (2009) Synthesis and biological activity of a novel series of 6-substituted thieno[2,3-d]pyrimidine antifolate inhibitors of purine biosynthesis with selectivity for high affinity folate receptors over the reduced folate carrier and proton-coupled folate transporter for cellular entry. J Med Chem 52(9):2940-2951.
52. Wang L, et al. (2011) Synthesis, biological, and antitumor activity of a highly potent 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate inhibitor with proton-coupled folate transporter and folate receptor selectivity over the reduced folate carrier that inhibits β-glycinamide ribonucleotide formyltransferase. J Med Chem 54(20): 7150-7164.
53. Yang J, Chen H, Vlahov IR, Cheng JX, Low PS (2007) Characterization of the pH of folate receptor-containing endosomes and the rate of hydrolysis of internalized acidlabile folate-drug conjugates. J Pharmacol Exp Ther 321(2):462-468.
54. Antony AC, Kincade RS, Verma RS, Krishnan SR (1987) Identification of high affinity folate binding proteins in human erythrocyte membranes. J Clin Invest 80(3):711-723.
55. Low PS, Antony AC (2004) Folate receptor-targeted drugs for cancer and inflammatory diseases. Adv Drug Deliv Rev 56(8):1055-1058.
56. Sabharanjak S, Sharma P, Parton RG, Mayor S (2002) GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independent pinocytic pathway. Dev Cell 2(4):411-423.
57. Monaco HL (1997) Crystal structure of chicken riboflavin-binding protein. EMBO J 16(7):1475-1483.
58. Holm L, Kääriäinen S, Rosenström P, Schenkel A (2008) Searching protein structure databases with DaliLite v.3. Bioinformatics 24(23):2780-2781.
59. Hasegawa H, Holm L (2009) Advances and pitfalls of protein structural alignment. Curr Opin Struct Biol 19(3):341-348.
60. Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA (2001) Electrostatics of nanosystems: Application to microtubules and the ribosome. Proc Natl Acad Sci USA 98(18): 10037-10041.
61. Pettersen EF, et al. (2004) UCSF Chimera-A visualization system for exploratory research and analysis. J Comput Chem 25(13):1605-1612.
62. Goddard TD, Huang CC, Ferrin TE (2007) Visualizing density maps with UCSF Chimera. J Struct Biol 157(1):281-287.
63. Leamon CP, Low PS (1991) Delivery of macromolecules into living cells: A method that exploits folate receptor endocytosis. Proc Natl Acad Sci USA 88(13):5572-5576.
64. Reddy JA, et al. (2007) Folate receptor-specific antitumor activity of EC131, a folatemaytansinoid conjugate. Cancer Res 67(13):6376-6382.
65. Theti DS, et al. (2003) Selective delivery of CB300638, a cyclopenta[g]quinazolinebased thymidylate synthase inhibitor into human tumor cell lines overexpressing the alpha-isoform of the folate receptor. Cancer Res 63(13):3612-3618.
66. Leahy DJ, Dann CE, 3rd, Longo P, Perman B, Ramyar KX (2000) A mammalian expression vector for expression and purification of secreted proteins for structural studies. Protein Expr Purif 20(3):500-506.
67. Fischer C, Rothenberg SP, da Costa M (1978) Preparation of a stable folate-sepharose complex for affinity chromatography. Anal Biochem 85(1):15-19.
68. Nishino T, Nishino T, Tsushima K (1981) Purification of highly active milk xanthine oxidase by affinity chromatography on Sepharose 4B/folate gel. FEBS Lett 131(2): 369-372.
69. Pierce MM, Raman CS, Nall BT (1999) Isothermal titration calorimetry of proteinprotein interactions. Methods 19(2):213-221.
70. Jarvis DL (2003) Developing baculovirus-insect cell expression systems for humanized recombinant glycoprotein production. Virology 310(1):1-7.
71. Hitchman RB, Locanto E, Possee RD, King LA (2011) Optimizing the baculovirus expression vector system. Methods 55(1):52-57.
72. Otwinowski Z, Minor W (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276:307-326.
73. McCoy AJ, et al. (2007) Phaser crystallographic software. J Appl Cryst 40(Pt 4):658-674.
74. Adams PD, et al. (2004) Recent developments in the PHENIX software for automated crystallographic structure determination. J Synchrotron Radiat 11(Pt 1):53-55.
75. Terwilliger TC, et al. (2008) Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard. Acta Crystallogr D Biol Crystallogr 64(Pt 1):61-69.
76. Murshudov GN, Vagin AA, Dodson EJ (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53(Pt 3): 240-255.
77. Emsley P, Cowtan K (2004) Coot: Model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60(Pt 12 Pt 1):2126-2132.
78. Winn MD, Isupov MN, Murshudov GN (2001) Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr D Biol Crystallogr 57(Pt 1):122-133.